SEATTLE & TAMPA, Fla.--(BUSINESS WIRE)--Rosetta Biosoftware announced today that the H. Lee Moffitt Cancer Center & Research Institute licensed the Rosetta Resolver® system. The Resolver system will be used to add support for collaborations and data exchange, and to analyze gene expression data generated by the Institute's Total Cancer Care program for discovery of biomarkers that will advance the future of cancer research.
